HQD CIRAK 2: New E-cigarette with Upgraded Features

Apr.03.2025
HQD CIRAK 2: New E-cigarette with Upgraded Features
HQD launches new e-cigarette CIRAK 2 with upgraded features and two pod options, now available on European websites.

Special statement:

This article is only for internal industry communication and does not make any recommendations for brands or products.

The images presented in this article are only used to describe facts and are not intended as advertisements for any products.

Minors are prohibited from accessing this article.


Product highlights:

HQD has launched a new e-cigarette product, the CIRAK 2, on its brand website. 

The CIRAK 2 offers two pod options: pre-filled oil pods and refillable open pods. Compared to the previous model, the CIRAK 2 features a larger battery capacity of 650mAh and an increased flavor variety from 12 to 15 options. 

The product is now available on select e-cigarette distributor websites in Europe, with prices starting at 9.9 euros.

 

As early as the end of 23, HQD had already launched the CIRAKe-cigarette, and the new CIRAK 2 appears to be an upgraded version of the previous product. 2Firsts compared the product parameters of HQD CIRAK and HQD CIRAK 2 e-cigarettes, as shown in the table below.

 

HQD CIRAK 2: New E-cigarette with Upgraded Features
HQD CIRAK 2 and HQD CIRAK Comparison of Parameters | Design: Two Supremes

 

According to the chart, the new HQD CIRAK 2 has a smaller product size, while the battery capacity has increased from 370 mAh in the HQD CIRAK to 650 mAh. The product now comes in 15 flavors, up from 12, and a refillable pod option has been added.

 

Sales information

 

It is worth noting that on the HQDEUROPE website, the HQD CIRAK 2 is classified under the category of HQD E-Shisha e-cigarettes, specifically waterpipe-style e-cigarettes. The price of e-cigarette devices (excluding pods) is 9.9 euros. Other e-cigarette products in this category include SURV, Hoova+, and SURV+.

 

HQD CIRAK 2: New E-cigarette with Upgraded Features
HQD CIRAK 2 sales interface | Image source: HQDEUROPE

 

The Prefilled Cartridge POD, CIRAK 2 Refillable Cartridge POD, and HQD JUICE used in conjunction with the HQD CIRAK 2 e-cigarette are now available on the HQDEUROPE website.

 

A box of Prefilled Cartridge PODs (including two pods) is priced at 9.9 euros, with a special price of 39.9 euros for a pack of ten. A box of CIRAK 2 Refillable Cartridges (including two pods, e-liquid not included) is priced at 7.9 euros, with a special price of 34.9 euros for a pack of ten. A bottle of e-liquid is priced at 9.9 euros, with a special price of 39.9 euros for a pack of five, available in a total of 15 different flavors.

 

 

HQD CIRAK 2: New E-cigarette with Upgraded Features
HQD Apprentice 2 related product sales page | Image source: HQD Europe

The new HQD CIRAK 2 and new HQD CIRAK e-cigarette have been launched on e-cigarette distributor websites in the German region, with simultaneous announcements on the HQD European official website and official social media accounts.

 

Manufacturer Information

 

The HQD brand is a subsidiary of Shenzhen HQD Technology Co., Ltd, which was established in 2014. In late 2024 and early 2025, the company launched two new products under the brand - the HQD FLEX featuring a '2+10' and '4 in 1' fusion, and the HQD CLICK PLUS dual e-liquid pod system.

 

A search of the UK Medicines and Healthcare products Regulatory Agency (MHRA) e-cigarette database did not find any application or public information for the new product "HQD CIRAK 2.

 

HQD CIRAK 2: New E-cigarette with Upgraded Features
HQD Apprentice public information|Image source: MHRA.

 

2FIRSTS Product Column has always focused on providing readers with the latest product information in the tobacco industry, aiming to gather and share first-hand information within the industry. We welcome readers to submit contributions and share the latest products in the e-cigarette field with us.

 

If you have any unique insights or information, please feel free to contact us at info@2firsts.com or reach out to 2Firsts CEO Alan Zhao on LinkedIn.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

FDA Grants PMTA Authorization to 11 ZYN ULTRA Nicotine Pouches, Bringing Total Authorized Pouches to 43
FDA Grants PMTA Authorization to 11 ZYN ULTRA Nicotine Pouches, Bringing Total Authorized Pouches to 43
The U.S. Food and Drug Administration authorized 11 ZYN ULTRA nicotine pouch products made by Swedish Match USA through the premarket tobacco product application pathway on August 21, 2026. Ten of the authorized products have a labeled nicotine content of 9 mg, while ZYN ULTRA Smooth was authorized at 11 mg. The reviews were conducted through FDA’s nicotine pouch PMTA pilot program. FDA has now authorized 43 nicotine pouch products, including 23 through the pilot.
Aug.24
2Firsts Interview | Cigarette Sales Fall as Smokeless Alternatives Gain in U.S. Convenience Stores, NACS Says
2Firsts Interview | Cigarette Sales Fall as Smokeless Alternatives Gain in U.S. Convenience Stores, NACS Says
Ahead of the 2026 NACS Show, 2Firsts interviewed Chris Rapanick, NACS managing director of research, on changes reshaping the U.S. convenience-store tobacco and nicotine market. NACS data show cigarette sales declining while smokeless alternatives, including nicotine pouches, continue to grow. The interview also examines higher OTP margins, shifting backbar space, weaker store traffic, regulatory uncertainty and NACS’ outlook for 2027, offering a retailer-side view of one of the world’s largest nicotine markets.
Interview
Oct.03
From Border-Logistics Insiders to Retail Service Stations, Australia Mounts a Sweeping Crackdown on the Illicit Nicotine Trade as iGET Vapes Surface in A$80 Million Crime Networks
From Border-Logistics Insiders to Retail Service Stations, Australia Mounts a Sweeping Crackdown on the Illicit Nicotine Trade as iGET Vapes Surface in A$80 Million Crime Networks
Australian authorities have disclosed two major enforcement actions that go beyond product seizures and retail closures to examine how illicit tobacco and vape networks operate. On Aug. 14, the Multi Agency Strike Team said seven people had been charged and two criminal networks were valued by authorities at a combined A$80 million, or about US$56.8 million. Investigators allege the groups used bonded warehouses, freight businesses and “trusted insiders” in legitimate industries to circumvent border controls. In a separate operation on Aug. 11, more than 100 service stations were targeted as authorities sought information on illicit tobacco importation, distribution networks and the movement of sales proceeds.
Aug.17
 PMI Opens Generative AI Center in Portugal to Support Global Operations
PMI Opens Generative AI Center in Portugal to Support Global Operations
According to information released by Portugal’s Trade & Investment Agency (AICEP) in July 2026, Philip Morris International (PMI) has established a global Generative Artificial Intelligence Factory (GenAI Factory) at its Portuguese subsidiary Tabaqueira. The center will support PMI’s global operations by developing and deploying AI solutions focused on industrial process optimization, data analytics, operational automation and AI application development. The initiative strengthens Portugal’s role in PMI’s global technology and innovation network.
Aug.27
From a 2017 Launch to 48% of South Korea’s Heated Tobacco Market, KT&G Looks Back on a Decade of lil
From a 2017 Launch to 48% of South Korea’s Heated Tobacco Market, KT&G Looks Back on a Decade of lil
KT&G announced on Aug. 13, 2026, that it has opened “lil Archive,” a brand exhibition space in Seoul showcasing the evolution, technology platforms and future direction of its heated tobacco brand lil since its launch in 2017. KT&G said lil now spans three major platforms — lil SOLID, lil HYBRID and lil AIBLE — with more than 30 dedicated consumables, and held a 48% share of South Korea's heated tobacco market in the second quarter of 2026. The opening comes as lil enters its 10th year, with KT&G continuing to position the brand for expansion beyond its domestic market.
Aug.14
Special Report | How Capital Is Reassessing the Global Tobacco and Modern Nicotine Industry: Lessons from a New York Forum
Special Report | How Capital Is Reassessing the Global Tobacco and Modern Nicotine Industry: Lessons from a New York Forum
Capital is reassessing the global tobacco and modern nicotine industry as heated tobacco, vaping and nicotine pouches reshape demand, profitability and regulation. At the 2026 New Approaches Summit in New York, investors and analysts examined whether smoke-free growth can sustain earnings, how regulation shapes startup value, and whether shareholder engagement can be more effective than divestment. The debate points to a broader shift: tobacco transition is increasingly becoming a capital-allocation, governance and valuation question.
Capital Markets
Oct.05